Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services, has scheduled its second quarter 2025 financial results announcement for Monday, August 11, 2025, after market close.
The company will host a conference call and webcast at 2:00 p.m. PT/ 5:00 p.m. ET on the same day. Investors can join via phone by dialing (800) 267-6316 or (203) 518-9783 with Conference ID MARAVAI, or access the webcast through the "Investors" section of Maravai's website.
Maravai LifeSciences (NASDAQ: MRVI), fornitore globale di reagenti e servizi per le scienze della vita, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per lunedì 11 agosto 2025, dopo la chiusura del mercato.
La società terrà una conference call e una webcast alle 14:00 PT / 17:00 ET dello stesso giorno. Gli investitori potranno partecipare telefonicamente chiamando il numero (800) 267-6316 o (203) 518-9783 con ID conferenza MARAVAI, oppure accedere alla webcast tramite la sezione "Investitori" del sito web di Maravai.
Maravai LifeSciences (NASDAQ: MRVI), proveedor global de reactivos y servicios para ciencias de la vida, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el lunes 11 de agosto de 2025, después del cierre del mercado.
La compañía realizará una llamada en conferencia y una transmisión en vivo a las 2:00 p.m. PT / 5:00 p.m. ET ese mismo día. Los inversores pueden unirse por teléfono marcando (800) 267-6316 o (203) 518-9783 con ID de conferencia MARAVAI, o acceder a la transmisión en vivo a través de la sección "Inversores" del sitio web de Maravai.
Maravai LifeSciences (NASDAQ: MRVI)는 생명과학 시약 및 서비스를 제공하는 글로벌 기업으로, 2025년 2분기 재무 실적 발표를 2025년 8월 11일 월요일 장 마감 후에 예정하고 있습니다.
회사는 같은 날 오후 2시 PT / 오후 5시 ET에 컨퍼런스 콜 및 웹캐스트를 진행할 예정입니다. 투자자들은 (800) 267-6316 또는 (203) 518-9783으로 전화하여 회의 ID MARAVAI를 입력하거나, Maravai 웹사이트의 "투자자" 섹션을 통해 웹캐스트에 접속할 수 있습니다.
Maravai LifeSciences (NASDAQ : MRVI), fournisseur mondial de réactifs et services en sciences de la vie, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le lundi 11 août 2025, après la clôture des marchés.
La société organisera une conférence téléphonique et une diffusion en direct à 14h00 PT / 17h00 ET le même jour. Les investisseurs peuvent participer par téléphone en composant le (800) 267-6316 ou le (203) 518-9783 avec l'identifiant de conférence MARAVAI, ou accéder à la diffusion via la section "Investisseurs" du site web de Maravai.
Maravai LifeSciences (NASDAQ: MRVI), ein globaler Anbieter von Reagenzien und Dienstleistungen für die Lebenswissenschaften, hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für Montag, den 11. August 2025, nach Börsenschluss, geplant.
Das Unternehmen wird am selben Tag um 14:00 Uhr PT / 17:00 Uhr ET eine Telefonkonferenz und eine Webcast veranstalten. Investoren können telefonisch unter (800) 267-6316 oder (203) 518-9783 mit der Konferenz-ID MARAVAI teilnehmen oder den Webcast über den Bereich "Investoren" auf der Maravai-Website verfolgen.
- None.
- None.
SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 financial and operating results after the market close on Monday, August 11, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (800) 267-6316 or (203) 518-9783 and reference Maravai LifeSciences, Conference ID MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
Contact Information: Deb Hart Maravai LifeSciences + 1 858-988-5917 ir@maravai.com
FAQ
When will Maravai LifeSciences (MRVI) release Q2 2025 earnings?
What time is Maravai LifeSciences Q2 2025 earnings call?
How can I access Maravai LifeSciences (MRVI) Q2 2025 earnings call?
What does Maravai LifeSciences (MRVI) do?
